(NDAQ) Nasdaq - Overview
Sector: Financial Services | Industry: Financial Data & Stock Exchanges | Exchange: NASDAQ (USA) | Market Cap: 50.299m USD | Total Return: 19.7% in 12m
Market Data, Trading Platforms, Listing Services, Financial Technology
Total Rating 59
Safety 72
Buy Signal -0.28
Financial Data & Stock Exchanges
Industry Rotation: -27.7
Industry Rotation: -27.7
Market Cap:
50.3B
Avg Turnover: 227M USD
Avg Turnover: 227M USD
ATR:
2.80%
Peers RS (IBD): 44.1
Peers RS (IBD): 44.1
Risk 5d forecast
Volatility31.7%
Rel. Tail Risk-1.37%
Reward TTM
Sharpe Ratio0.60
Alpha-3.84
Character TTM
Beta0.771
Beta Downside0.826
Drawdowns 3y
Max DD21.76%
CAGR/Max DD0.76
EPS (Earnings per Share)
EPS CAGR: 10.51%
EPS Trend: 82.3%
EPS Trend: 82.3%
Last SUE: 2.30
Qual. Beats: 3
Qual. Beats: 3
Revenue
Rev. CAGR: 8.44%
Rev. Trend: 87.9%
Rev. Trend: 87.9%
Last SUE: 3.61
Qual. Beats: 1
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: NDAQ Nasdaq
Nasdaq, Inc. (NDAQ) is a technology company supporting capital markets globally. It operates through three segments: Capital Access Platforms, Financial Technology, and Market Services.
The company provides market data, develops financial products, and offers investor relations, governance, and sustainability solutions. Its Financial Technology segment includes anti-financial crime platforms like Verafin and regulatory reporting tools such as AxiomSL. The Market Services segment operates various exchanges for equities, derivatives, and commodities, also providing clearing and settlement services. Financial Exchanges & Data is a GICS sub-industry. To continue your research on NDAQ and its industry, consider exploring ValueRay.
- Market data and index licensing revenue growth
- Financial technology solutions drive recurring revenue
- Regulatory reporting demand impacts software sales
- Trading volumes influence transaction-based income
- Interest rate changes affect clearing and settlement revenue
Piotroski VR‑10 (Strict)
6.0
| Net Income: 1.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.71 > 1.0 |
| NWC/Revenue: 0.51% < 20% (prev -1.57%; Δ 2.08% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.25b > Net Income 1.79b |
| Net Debt (9.11b) to EBITDA (3.13b): 2.91 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (576.5m) vs 12m ago -0.43% < -2% |
| Gross Margin: 47.93% > 18% (prev 0.40%; Δ 4.75k% > 0.5%) |
| Asset Turnover: 26.75% > 50% (prev 24.34%; Δ 2.41% > 0%) |
| Interest Coverage Ratio: 7.01 > 6 (EBITDA TTM 3.13b / Interest Expense TTM 356.0m) |
Altman Z''
2.00
| A: 0.00 (Total Current Assets 8.00b - Total Current Liabilities 7.96b) / Total Assets 31.05b |
| B: 0.31 (Retained Earnings 9.59b / Total Assets 31.05b) |
| C: 0.08 (EBIT TTM 2.49b / Avg Total Assets 30.72b) |
| D: 0.42 (Book Value of Equity 7.82b / Total Liabilities 18.82b) |
| Altman-Z'' Score: 2.00 = BBB |
Beneish M
-3.25
| DSRI: 0.83 (Receivables 943.0m/1.02b, Revenue 8.22b/7.40b) |
| GMI: 0.84 (GM 47.93% / 40.42%) |
| AQI: 0.99 (AQ_t 0.70 / AQ_t-1 0.71) |
| SGI: 1.11 (Revenue 8.22b / 7.40b) |
| TATA: -0.02 (NI 1.79b - CFO 2.25b) / TA 31.05b) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
What is the price of NDAQ shares?
As of April 12, 2026, the stock is trading at USD 83.16 with a total of 3,305,615 shares traded.
Over the past week, the price has changed by -5.39%, over one month by -4.77%, over three months by -16.09% and over the past year by +19.73%.
Over the past week, the price has changed by -5.39%, over one month by -4.77%, over three months by -16.09% and over the past year by +19.73%.
Is NDAQ a buy, sell or hold?
Nasdaq has received a consensus analysts rating of 3.95.
Therefore, it is recommended to buy NDAQ.
- StrongBuy: 6
- Buy: 7
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the NDAQ price?
| Analysts Target Price | 108.2 | 30.1% |
Nasdaq (NDAQ) - Fundamental Data Overview
as of 10 April 2026
P/E Trailing = 28.5081 P/E Forward = 22.5734
P/S = 9.5826
P/B = 4.0284
P/EG = 2.1089
Revenue TTM = 8.22b USD
EBIT TTM = 2.49b USD
EBITDA TTM = 3.13b USD
Long Term Debt = 8.57b USD (from longTermDebt, last quarter)
Short Term Debt = 431.0m USD (from shortTermDebt, last quarter)
Debt = 9.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.11b USD (from netDebt column, last quarter)
Enterprise Value = 59.38b USD (50.30b + Debt 9.93b - CCE 842.0m)
Interest Coverage Ratio = 7.01 (Ebit TTM 2.49b / Interest Expense TTM 356.0m)
EV/FCF = 29.86x (Enterprise Value 59.38b / FCF TTM 1.99b)
FCF Yield = 3.35% (FCF TTM 1.99b / Enterprise Value 59.38b)
FCF Margin = 24.20% (FCF TTM 1.99b / Revenue TTM 8.22b)
Net Margin = 21.77% (Net Income TTM 1.79b / Revenue TTM 8.22b)
Gross Margin = 47.93% ((Revenue TTM 8.22b - Cost of Revenue TTM 4.28b) / Revenue TTM)
Gross Margin QoQ = 66.92% (prev 44.43%)
Tobins Q-Ratio = 1.91 (Enterprise Value 59.38b / Total Assets 31.05b)
Interest Expense / Debt = 0.89% (Interest Expense 88.0m / Debt 9.93b)
Taxrate = 10.52% (61.0m / 580.0m)
NOPAT = 2.23b (EBIT 2.49b * (1 - 10.52%))
Current Ratio = 1.01 (Total Current Assets 8.00b / Total Current Liabilities 7.96b)
Debt / Equity = 0.81 (Debt 9.93b / totalStockholderEquity, last quarter 12.23b)
Debt / EBITDA = 2.91 (Net Debt 9.11b / EBITDA 3.13b)
Debt / FCF = 4.58 (Net Debt 9.11b / FCF TTM 1.99b)
Total Stockholder Equity = 11.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.82% (Net Income 1.79b / Total Assets 31.05b)
RoE = 15.03% (Net Income TTM 1.79b / Total Stockholder Equity 11.90b)
RoCE = 12.18% (EBIT 2.49b / Capital Employed (Equity 11.90b + L.T.Debt 8.57b))
RoIC = 10.60% (NOPAT 2.23b / Invested Capital 21.05b)
WACC = 7.39% (E(50.30b)/V(60.23b) * Re(8.69%) + D(9.93b)/V(60.23b) * Rd(0.89%) * (1-Tc(0.11)))
Discount Rate = 8.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.32%
[DCF] Terminal Value 82.13% ; FCFF base≈1.89b ; Y1≈2.10b ; Y5≈2.76b
[DCF] Fair Price = 81.29 (EV 55.32b - Net Debt 9.11b = Equity 46.21b / Shares 568.4m; r=7.39% [WACC]; 5y FCF grow 13.13% → 3.0% )
EPS Correlation: 82.34 | EPS CAGR: 10.51% | SUE: 2.30 | # QB: 3
Revenue Correlation: 87.87 | Revenue CAGR: 8.44% | SUE: 3.61 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.96 | Chg7d=-0.001 | Chg30d=+0.000 | Revisions Net=+3 | Analysts=13
EPS current Year (2026-12-31): EPS=3.91 | Chg7d=-0.004 | Chg30d=-0.000 | Revisions Net=+5 | Growth EPS=+12.3% | Growth Revenue=+8.6%
EPS next Year (2027-12-31): EPS=4.38 | Chg7d=-0.020 | Chg30d=+0.007 | Revisions Net=+2 | Growth EPS=+12.1% | Growth Revenue=+8.2%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.2% (Discount Rate 8.7% - Earnings Yield 3.5%)
[Growth] Growth Spread = +3.3% (Analyst 8.5% - Implied 5.2%)
External Resources